Skip to main content

Table 2 Levels of the monitored indices before and after the 12-week supplementation with HMB preparation and placebo

From: The efficacy of a β-hydroxy-β-methylbutyrate supplementation on physical capacity, body composition and biochemical markers in elite rowers: a randomised, double-blind, placebo-controlled crossover study

Research period

 

PREHMB vs. PLA

HMB

Difference

PLACEBO

Difference

 

p valuea

p valueb

p valueb

BM (kg)

Pre

0.925

86.5 ± 9.3

0.016

86.2 ± 9.0

0.063

Post

 

84.6 ± 8.1

84.8 ± 8.5

FFM (kg)

Pre

0.921

72.7 ± 6.3

0.117

72.9 ± 6.1

0.001

Post

 

71.7 ± 5.6

70.9 ± 5.7

FM (kg)

Pre

0.755

13.8 ± 4.4

0.073

13.3 ± 4.7

0.197

Post

 

12.8 ± 4.0

14.1 ± 4.3

\( \dot{\mathrm{V}}{\mathrm{O}}_2 \max \) (mL · min−1)

Pre

0.681

5794 ± 676

0.240

5897 ± 735

0.067

Post

 

5905 ± 709

5723 ± 745

\( \dot{\mathrm{V}}{\mathrm{O}}_2 \max \) (mL · min−1 · kg−1)

Pre

0.572

67.3 ± 6.9

0.033

68.8 ± 8.0

0.438

Post

 

70.0 ± 6.9

67.8 ± 8.5

Tref (min)

Pre

0.947

17.6 ± 3.1

0.043

17.7 ± 3.1

0.233

Post

 

19.0 ± 3.6

18.5 ± 3.7

Wmax (W)

Pre

0.777

372 ± 52

0.052

378 ± 52

0.625

Post

 

397 ± 56

384 ± 60

Wmax (W · kg−1)

Pre

0.621

4.31 ± 0.50

0.039

4.39 ± 0.41

0.234

Post

 

4.70 ± 0.55

4.55 ± 0.65

HRmax (bpm)

Pre

0.962

185 ± 13

0.258

185 ± 9

0.136

Post

 

188 ± 9

188 ± 10

TVT (min)

Pre

0.440

12.5 ± 2.1

0.003

12.8 ± 1.9

0.619

Post

 

13.7 ± 2.2

12.6 ± 2.6

WVT (W)

Pre

0.187

278 ± 41

0.012

294 ± 36

0.310

Post

 

309 ± 42

284 ± 47

WVT (W · kg−1)

Pre

0.248

3.24 ± 0.51

0.001

3.42 ± 0.32

0.554

Post

 

3.66 ± 0.36

3.36 ± 0.49

HRVT (bpm)

Pre

0.399

157 ± 9

0.001

160 ± 10

0.598

Post

 

166 ± 11

161 ± 9

CK (U · L−1)

Pre

0.865

328 ± 160

0.004

348 ± 169

0.008

Post

 

241 ± 103

265 ± 156

LDH (U · L−1)

Pre

0.573

318 ± 36

0.033

326 ± 45

0.002

Post

 

302 ± 35

302 ± 39

Testosterone (mg · dL−1)

Pre

0.895

510 ± 202

0.352

510 ± 154

0.569

Post

 

552 ± 160

487 ± 160

Cortisol (mg · dL−1)

Pre

0.585

19.9 ± 5.3

0.331

20.0 ± 5.9

0.516

Post

20.6 ± 5.8

20.8 ± 4.1

T/C ratio (T · C−1*10−2)

Pre

0.51

3.39 ± 1.77

0.53

3.36 ± 0.99

0.30

Post

 

3.41 ± 1.08

3.03 ± 1.11

Peak power (W)

Pre

0.615

1003 ± 125

0.027

1028 ± 147

0.853

Post

 

1054 ± 116

1024 ± 122

Peak power (W · kg−1)

Pre

0.488

11.65 ± 1.01

0.020

11.92 ± 1.16

0.960

Post

 

12.26 ± 0.83

11.91 ± 1.15

Average power (W)

Pre

0.924

725 ± 87

0.648

722 ± 87

0.660

Post

 

720 ± 83

718 ± 82

Average power (W · kg−1)

Pre

0.854

8.36 ± 0.60

0.688

8.32 ± 0.55

0.736

Post

 

8.30 ± 0.59

8.28 ± 0.65

Minimal power (W)

Pre

0.478

503 ± 75

0.095

486 ± 52

0.763

Post

 

475 ± 54

491 ± 78

Minimal power (W · kg−1)

Pre

0.465

5.80 ± 0.78

0.119

5.63 ± 0.55

0.821

Post

 

5.49 ± 0.53

5.67 ± 0.76

  1. Values are expressed as mean ± SD
  2. BM body mass, FFM fat-free mass, FM fat mass, \( \dot{V}{O}_2 max \) maximal oxygen uptake, Tref exercise time before athlete’s refusal to continue exercising, Wmax maximum load, HRmax maximum heart rate, VT ventilatory threshold, T VT time to VT, W VT load at VT, HR VT heart rate at VT, CK creatine kinase, LDH lactate dehydrogenase, T/C ratio testosterone/cortisol ratio
  3. aDepending on the data distribution: independent samples t-tests or Mann–Whitney U tests
  4. bDepending on the data distribution: dependent samples t-tests or Wilcoxon-signed rank tests